Modification To Variant Ii: Hemoglobin A1C Program, Beta-Thalassemia Short Program and Total Ghb Program
Assay, Glycosylated Hemoglobin. 510(k) K063643, from Bio-Rad Laboratories Inc., Clinical Systems Divisi (Hercules, CA). Product code LCP, class 2.
As of Nov 20, 2026, K063643 is an FDA 510(k) held by Bio-Rad Laboratories Inc., Clinical Systems Divisi, substantially equivalent on Dec 27, 2006 after 20 days, with 1 recall tied to it in FDA's recall database.
- Review time: 20 days
- Recalls: 1
- Cited as a predicate by: 1 device
36 43 Device Name: VARIANTâ„¢ II Hemoglobin A1c Program, VARIANTâ„¢ II Beta-thalassemia and VARIANTâ„¢ II Total GHb run on the VARIANTâ„¢ II Hemoglobin Testing System with CDM 4.0 Indications For Use
- Variant Ii Hemoglobin A1C ProgramK984268 · Bio-Rad · Dec 17, 1998
- Variant Ii B-ThalassemiaK991127 · Bio-Rad · Jun 10, 1999
- Variant Ii Total GhbK003280 · Bio-Rad · Dec 19, 2000
- Variant Ii Hemoglobin A1C Program (New), Variant Ii Hemoglobin Testing System With Cdm Software, Cdm SoftwareK130860 · Bio-Rad Laboratories, Inc., Clinical Systems Divis · Apr 25, 2013
| Started | Recall | Status |
|---|---|---|
| Dec 9, 2008 | Z-1395-2009The wrong barcode number and tube position number may be assigned to samples leading to discrepant sample results. | Terminated |
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Dec 7, 2006
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files